P

Inventor

TANAKA HIROKO

US65 patents
⚠️ This page may combine multiple inventors who share the name “TANAKA HIROKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHEMOCENTRYX INC

31 patents
US10035768B2Jul 31, 2018

C5aR antagonists

CHEMOCENTRYX INC23 citations94
US9834545B2Dec 5, 2017

Modulators of chemokine receptors

CHEMOCENTRYX INC26 citations94
US9809581B2Nov 7, 2017

Inhibitors of CXCR2

CHEMOCENTRYX INC23 citations94
US9573897B2Feb 21, 2017

C5AR antagonists

CHEMOCENTRYX INC24 citations94
US8906938B2Dec 9, 2014

C5aR antagonists

CHEMOCENTRYX INC28 citations92
US9745268B2Aug 29, 2017

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC11 citations91
US10562896B2Feb 18, 2020

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC11 citations86
US11384079B2Jul 12, 2022

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC5 citations84
US10828285B2Nov 10, 2020

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC5 citations84
US10660897B2May 26, 2020

C5aR antagonists

CHEMOCENTRYX INC6 citations84
US10532982B2Jan 14, 2020

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC4 citations84
US10464934B2Nov 5, 2019

Substituted tetrahydropyrans as CCR2 modulators

CHEMOCENTRYX INC5 citations84
US10370363B2Aug 6, 2019

Inhibitors of CXCR2

CHEMOCENTRYX INC6 citations84
US10336736B2Jul 2, 2019

Modulators of chemokine receptors

CHEMOCENTRYX INC6 citations84
US10266492B2Apr 23, 2019

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC8 citations84
US9783540B2Oct 10, 2017

Substituted tetrahydropyrans as CCR2 modulators

CHEMOCENTRYX INC7 citations84
US9750722B2Sep 5, 2017

Diazole amides

CHEMOCENTRYX INC5 citations84
US9328116B2May 3, 2016

Diazole lactams

CHEMOCENTRYX INC4 citations84
US9169248B2Oct 27, 2015

Diazole amides

CHEMOCENTRYX INC6 citations84
US9340509B2May 17, 2016

CCR6 compounds

CHEMOCENTRYX INC4 citations82
US11478460B2Oct 25, 2022

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC3 citations73
US11434230B2Sep 6, 2022

2-oxindole compounds

CHEMOCENTRYX INC1 citations73
US11040960B2Jun 22, 2021

Inhibitors of CXCR2

CHEMOCENTRYX INC3 citations73
US10988464B2Apr 27, 2021

Modulators of chemokine receptors

CHEMOCENTRYX INC3 citations73
US10759789B2Sep 1, 2020

2-oxindole compounds

CHEMOCENTRYX INC2 citations73
US10744118B2Aug 18, 2020

Diazole lactams

CHEMOCENTRYX INC2 citations73
US10421748B2Sep 24, 2019

2-oxindole compounds

CHEMOCENTRYX INC3 citations73
US9795599B2Oct 24, 2017

CCR6 compounds

CHEMOCENTRYX INC2 citations72
US12268675B2Apr 8, 2025

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC0 citations63
US11773091B2Oct 3, 2023

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC0 citations63
US12139475B2Nov 12, 2024

2-oxindole compounds

CHEMOCENTRYX INC0 citations62

NURIX THERAPEUTICS INC

6 patents

TEIJIN LTD

5 patents

FAN PINGCHEN

2 patents

MILLENNIUM PHARM INC

2 patents

SHARP KK

1 patent

BIOGEN IDEC INC

1 patent

TEIJIN INTELLECTUAL PROPERTY C

1 patent

CHEN WEIRONG

1 patent

Showing the top 50 of 65 patents by PatentIndex Score.